BDX
Becton, Dickinson and Company
NYSE · USHealthcareMedical - Instruments & Supplies
$154.48-2.33%
Price as of Jul 20, 2026
BDX profitability
Becton, Dickinson and Company profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 46.5%
- EBITDA margin
- 21.9%
- EBIT margin
- 10.6%
- Net margin
- 5.3%
- Free cash flow margin
- 14.7%
Returns
- Return on equity
- 4.7%
- Return on assets
- 2.2%
- Return on invested capital
- 5.5%
- Asset turnover
- 0.40x
Cash efficiency
- Cash from operations
- $3.9B
- Cash per share
- $2.96
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.